Opioids · ICD-10 F11.10

Opioid Use Disorder in Louisville, KY

Name: Golden Grove Recovery
Address: 4418 Malcolm Ave, Louisville, KY, 40211, US
Telephone: (502) 610-4829
Price range: $$

Opioid Use Disorder (OUD) is a chronic, treatable brain disease defined by compulsive opioid use despite harmful consequences.

Call (502) 610-4829 Verify Insurance

Overview

What opioid use disorder looks like.

Opioid Use Disorder (OUD) is a chronic, treatable brain disease defined by compulsive opioid use despite harmful consequences. OUD includes addictions to prescription pain medications (oxycodone, hydrocodone), heroin, and illicit fentanyl. Medication-Assisted Treatment (MAT) paired with behavioral therapy is the clinical standard of care and is associated with the largest reductions in overdose mortality.

Also known as: opioid addiction, opiate addiction, OUD, narcotic addiction.

Signs of use

What patients and families actually notice.

Taking opioids in larger amounts or for longer than intended
Unsuccessful attempts to cut down or stop
Spending significant time obtaining, using, or recovering from opioids
Strong cravings or urges to use
Failing work, family, or school obligations due to opioid use
Continued use despite social or interpersonal problems
Using in physically hazardous situations (e.g., driving)
Tolerance (needing more for the same effect) and withdrawal when stopping

Withdrawal timeline

What withdrawal tends to look like.

Every person's experience varies. The windows below describe typical clinical patterns — your care team adjusts the plan based on how you respond.

6–12 hours (short-acting) / 24–48 hours (long-acting)

— Anxiety
— yawning
— muscle aches
— lacrimation
— runny nose
— sweating
— insomnia

1–3 days

— Peak discomfort: nausea
— vomiting
— diarrhea
— abdominal cramps
— dilated pupils
— piloerection ("cold turkey")

3–7 days

— Acute physical symptoms subside
— residual insomnia
— dysphoria
— cravings

Weeks 2–8+

— Post-acute withdrawal: mood disturbance
— anhedonia
— sleep disruption
— persistent cravings — highest relapse-risk window

Treatment approach

How we treat opioid use disorder.

Medical detox with MAT induction

Supervised withdrawal with clinical monitoring. Buprenorphine (Suboxone/Subutex) induction is often started during detox to reduce severity and prevent relapse.

Learn more →

Residential treatment

Residential care addresses behavioral and psychological drivers of OUD and stabilizes MAT dosing.

Learn more →

Medication-Assisted Treatment

Suboxone, Subutex, methadone, and Vivitrol are all FDA-approved for OUD. MAT reduces overdose risk by more than 50% when continued long-term.

Learn more →

Step-down care

PHP, IOP, and outpatient maintain clinical contact during the highest-risk post-residential window.

Integrated dual-diagnosis care

OUD co-occurs with depression, anxiety, PTSD, and ADHD at very high rates — integrated treatment improves outcomes.

Learn more →

In Kentucky

The local picture.

Kentucky continues to have one of the highest opioid overdose rates in the United States, driven primarily by illicit fentanyl. Louisville (Jefferson County) consistently ranks among the highest-impact counties. Kentucky Medicaid covers MAT for OUD across all six MCOs, and Kentucky law supports access to buprenorphine, methadone, and naloxone.

Kentucky Medicaid coverage

Opioid Use Disorder is typically covered.

Kentucky Medicaid plans typically cover MAT (Suboxone, Subutex, methadone, Vivitrol) and the clinical continuum of substance use treatment for OUD. Pharmacy prior authorization may apply to specific MAT formulations; methadone treatment is delivered only through licensed opioid treatment programs (OTPs).

Coverage is determined by medical necessity using ASAM criteria. Our admissions team verifies your specific plan during your first call.

Frequently asked

Questions we hear most often.

Is MAT (Suboxone, methadone) just trading one addiction for another?

No. Decades of clinical research show MAT is the most effective OUD treatment, reducing overdose deaths by more than half. MAT medications stabilize brain chemistry without producing the euphoria of misuse when taken as prescribed.

How long does MAT last?

MAT is individualized. Some people use it short-term during stabilization; most benefit from months or years of maintenance. There is no clinical evidence that shorter MAT duration improves long-term outcomes — the opposite is true.

Does Kentucky Medicaid cover opioid addiction treatment?

Yes. Kentucky Medicaid plans typically cover OUD treatment across the clinical continuum of substance use treatment, including MAT.

Other substances we treat

The full treatment scope.

Adderall Misuse and Stimulant Use Disorder

Alcohol Use Disorder

Benzodiazepine Addiction

Cocaine Addiction

Fentanyl Addiction

Heroin Addiction

Methamphetamine Addiction

Take the next step

Discuss opioid use disorder with our admissions team.

24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.

Call (502) 610-4829 Verify Insurance